TIP_link_300x300.jpg
$130.37Bn Hemodialysis and Peritoneal Dialysis Market 6.4% CAGR to 2028 Led by Hemodialysis (86.09% Revenue Share in 2022): The Insight Partners
May 27, 2022 02:47 ET | The Insight Partners
New York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Global Analysis...
22157.jpg
APAC Insulin Syringes Industry to 2027 - Players Include Novo Nordisk, Biocon, Eli Lilly and Company and Abbott Laboratories
May 24, 2022 05:58 ET | Research and Markets
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe...
22157.jpg
LAMEA Insulin Syringes Market (2021 to 2027) - Size, Share & Industry Trends Analysis Report
May 18, 2022 05:33 ET | Research and Markets
Dublin, May 18, 2022 (GLOBE NEWSWIRE) -- The "LAMEA Insulin Syringes Market Size, By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By End User, By Country and Growth Forecast,...
BB_Stacked_BW_TM_RGB.jpg
Beta Bionics Appoints Gilad Glick to the Board of Directors and Veena Rao, Ph.D. as Chief Commercial Officer
May 10, 2022 05:00 ET | Beta Bionics, Inc.
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Gilad Glick, former Chief Executive Officer,...
BB_Stacked_BW_TM_RGB.jpg
The iLet® Bionic Pancreas Significantly Reduced HbA1c and Improved Time in Range vs Standard of Care for a Diverse Range of People with Type 1 Diabetes
April 30, 2022 04:00 ET | Beta Bionics, Inc.
The trial achieved key primary and secondary endpoints, demonstrating improved outcomes over standard of care for people living with type 1 diabetes.The study population — 440 adults and children 6...
Diabeloop Presents New Real-Life Results of DBLG1® System
April 28, 2022 08:00 ET | Diabeloop SA
PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- At ATTD 2022 - Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, presents today new results from a real-life cohort in...
PolarSeal Announces Wearable Medical Device Solutions in the US to Change Outcomes for 88 Million People at Risk for Type 2 Diabetes
April 25, 2022 09:00 ET | PolarSeal
LONDON, April 25, 2022 (GLOBE NEWSWIRE) -- PolarSeal launches advanced in-house converting capabilities for adhesive tapes and medical grade materials to co-design and manufacture wearable medical...
BB_Stacked_BW_TM_RGB.jpg
Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD
April 25, 2022 05:00 ET | Beta Bionics, Inc.
Dr. Steven J. Russell will present the results from the multi-center randomized Insulin-Only Bionic Pancreas Pivotal Trial at the International Conference on Advanced Technologies & Treatments for...
22157.jpg
Global Insulin Syringes Market Size, Share & Industry Trends Analysis, 2022 Report Features Key Players Abbott Laboratories, Eli Lilly and Novo Nordisk Among Others
April 22, 2022 04:53 ET | Research and Markets
Dublin, April 22, 2022 (GLOBE NEWSWIRE) -- The "Global Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By...
researchdrivelogo.jpg
Growth: Global Urinalysis Market Estimated to Surpass $4,776.9 by 2028 and Grow at 6.3% CAGR in the 2021 to 2028 Timeframe [170-Pages] | Confirmed by Research Dive
March 29, 2022 09:01 ET | Research Dive
New York, USA, March 29, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global urinalysis market is anticipated to gather a revenue of $4,776.9 million by 2028 and...